A recent investigation of impaired cell membrane calcium transport and transient receptor potential melastatin 3 (TRPM3) reported dysfunction in both ME/CFS and LCov (Cabanas et al., 2018; Sasso et al., 2022). This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.